Paxlovid Boceprevir Intermediate CAS 565456-77-1 Kev Ntsuam Xyuas ≥99.0%
Kev Lag Luam Kev Lag Luam PF-07321332 Paxlovid Cov Khoom Siv Hluav Taws Xob nrog Cov Khoom Zoo
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
Tom ntej: 6,6-Dimethyl-3-azabicyclo [3.1.0]hexane CAS 943516-54-9
Tshuaj npe | (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride |
Synonyms | Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate Hydrochloride |
CAS Nr | 565456-77-1 |
CAT Number | Qauv: RF-PI318 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C9H15NO2.ClH |
Molecular Luj | 205.683 ib |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb rau Off-White Powder |
Kev Taw Qhia A | IR: Zoo ib yam li Cov Khoom Siv |
Kev Qhia B | Lub Sijhawm Khaws Cia: Zoo ib yam li Cov Khoom Siv |
Enantiomer | ≤ 0.15% |
Related Impurity (los ntawm HPLC) | |
Tsis paub impurity | ≤ 0.20% |
Tag nrho cov impurities | ≤ 1.0% |
Dej | ≤0.50% |
Residue ntawm Ignition | ≤0.10% |
Hnyav Hlau | ≤ 20ppm |
Assay | ≥99.0% |
Test Standard | Enterprise Standard |
Kev siv | Intermediate ntawm PF-07321332 Paxlovid (CAS 2628280-40-8) thiab Boceprevir (CAS 394730-60-0) |
Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride (CAS 565456-77-1) yog ib qho azabicyclohexane derivative siv los npaj cov kab mob siab C Tus kab mob (HCV) NS3 serine protease inhibitor.Nws yog qhov nruab nrab ntawm PF-07321332 Paxlovid (CAS 2628280-40-8) thiab Boceprevir (CAS 394730-60-0).PF-07321332 is a potent and orally active SARS-CoV 3C-like protease (3CLPRO) inhibitor .PF-07321332 lub hom phiaj rau tus kab mob SARS-CoV-2 thiab tuaj yeem siv rau COVID-19 reseacrch.Boceprevir (INN, lub npe lag luam Victrelis) yog ib qho protease inhibitor siv los kho kab mob siab C genotype 1. Nws khi rau HCV nonstructural 3 NS3 (HCV) active site.Nws tau raug tsim los ntawm Schering-Plough, tab sis tam sim no tau tsim los ntawm Merck txij li Schering tau txais hauv 2009. Nws tau pom zoo los ntawm FDA thaum lub Tsib Hlis 13, 2011.